American Invest Hub
  • Politics
  • Investing
  • Business
  • Latest News

American Invest Hub

  • Politics
  • Investing
  • Business
  • Latest News
Latest News

From Bunge’s Viterra deal to Shein’s IPO: US-China trade war derails major cross-border deals

by admin May 4, 2025
May 4, 2025
From Bunge’s Viterra deal to Shein’s IPO: US-China trade war derails major cross-border deals

Trade tensions between the United States and China are throwing a spanner in billions of dollars worth of acquisitions and initial public offerings, dealing a fresh blow to a dealmaking market that was already slow to recover this year.

Prevailing tensions between the two nations have reportedly stalled Bunge Global SA’s $8.2 billion acquisition of Viterra, as Chinese regulatory approval remains elusive.

According to people familiar with the matter reported by Bloomberg on Friday, Bunge executives, including CEO Greg Heckman, have made repeated trips to China, hoping to secure the green light.

But with the political rift deepening, concerns are growing that the process may drag on.

Bunge, one of the world’s largest agricultural commodity traders and a member of the so-called ABCD quartet, announced its intention to acquire Glencore-backed Viterra in June 2023.

The merger is set to create a $25 billion global powerhouse to challenge crop trading giants like Cargill Inc.

While the deal has passed regulatory hurdles in Europe and Canada, and is expected to proceed in Argentina, subject to post-closing remedies, China remains the major holdout.

Bunge stated it is in “constructive dialogue” with Chinese officials, but the lack of formal approval has become a sticking point.

Sources close to the matter say Beijing’s reluctance is not necessarily tied to competition concerns but is reflective of broader geopolitical tensions with the US.

China’s commerce ministry and antitrust regulator have not responded to requests for comment.

Shein’s London IPO faces delays as US ramps up tariffs

Chinese-founded fast-fashion giant Shein is also facing fallout from US-China tensions.

The company is considering a shake-up of its US operations as tariffs on Chinese imports put its planned London IPO at risk, according to a Financial Times report.

The company’s American division, which accounts for around one-third of Shein’s $38 billion in annual revenue, is expected to come under strain with the imminent expiration of a key tax exemption known as “de minimis,” the report said.

The de minimis rule expired on Friday.

Reuters reported on Friday that Shein had also severed ties with communications firms Brunswick and FGS, both of which were supporting its IPO strategy in London.

Their contracts expired on April 30 and will not be renewed, sources confirmed, in what the report said was another sign that the flotation was not going as planned.

Though Shein has received clearance from Britain’s financial regulator, it still requires approval from Chinese authorities.

With regulatory uncertainty on both ends and a hostile trade environment, the IPO, initially expected in the first half of the year, is now likely to be pushed into the latter half of 2025.

Wave of IPO postponements signals deeper market anxiety

The ripple effect of US-China trade tensions is being felt across global financial markets, with a growing list of companies delaying IPO plans.

Firms like Klarna Bank AB, Medline, and StubHub Holdings Inc. have all shelved their listing efforts in recent weeks due to heightened volatility sparked by Trump’s tariff announcements on April 2.

Offerings from adtech group MNTN Inc. and insurer Ategrity Specialty Holdings were also on hold, it was reported.

Trading platform EToro Group Ltd., had in April reportedly paused its IPO ambitions, but according to a Bloomberg report on Friday, it is now considering launching its US initial public offering as soon as next week.

Sources cited in the report caution, however, that no final decision has been made.

If EToro proceeds, it would be the first among the group of delayed IPOs to move forward following the tariff turmoil.

But the broader picture remains bleak: protectionist trade policies and retaliatory measures from China are weighing heavily on companies with global exposure, disrupting both M&A deals and capital-raising efforts.

The post From Bunge’s Viterra deal to Shein’s IPO: US-China trade war derails major cross-border deals appeared first on Invezz

0
FacebookTwitterGoogle +Pinterest
previous post
DXY Index: Chart shows the US Dollar Index crash is not over yet
next post
Analysis: OPEC’s accelerated output plan may keep oil prices volatile

Related Posts

Women and girls in Sudan subjected to widespread...

July 29, 2024

Japan’s exports rise, but trade deficit widens to...

November 20, 2024

Everything seems to be going wrong for Rishi...

April 21, 2024

Italian mafia boss who escaped prison by tying bed sheets...

February 3, 2024

Interview: ‘We anticipate short-term pricing pressures,’ says Euro...

March 6, 2025

Russia has recruited as many as 15,000 Nepalis...

February 13, 2024

Strapped down, blindfolded, held in diapers: Israeli whistleblowers...

May 11, 2024

What would happen to the US economy if...

April 21, 2025

Putin says Russia’s army is ‘always ready’ as...

May 10, 2024

Hamas-led groups committed ‘numerous war crimes’ on October...

July 21, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest News

    • Trump wants Apple to shift iPhone production from India to the US: here’s what it means

      May 18, 2025
    • Inflation outlook in 2025: what April’s soft data isn’t telling you

      May 18, 2025
    • Rich List 2025: UK billionaires decline for first time in years amid market turmoil

      May 18, 2025
    • Novo Nordisk CEO to step down as obesity drug competition intensifies

      May 18, 2025
    • Argentina’s black market for dollar falters as President Milei dismantles currency controls

      May 18, 2025

    Categories

    • Business (2,979)
    • Investing (2,438)
    • Latest News (1,990)
    • Politics (1,530)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: americaninvesthub.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 americaninvesthub.com | All Rights Reserved